PSA NSW Excellence Award winners announced

Four exemplary pharmacists were celebrated for their leadership, community impact, and commitment to health innovation.

Heading off patient harm from medicines

Medicine adherence, deprescribing and establishing systems to prevent error recurrence are all part of the pharmacist’s calling to protect patient safety. Pharmacists, as custodians of...

2022 is a year of action for PSA

Ahead of a federal election and an energised remuneration campaign, PSA‘s Communities of Specialty Interest are preparing to power pharmacy practice in 2022 and beyond. 

Dapagliflozin for infertility for women with obesity

This glucose-lowering diabetes drug may have therapeutic benefits and clinical utility for people with reproductive dysfunction.

Overcoming mythinformation

The COVID-19 pandemic is a victim of innuendo, conspiracy theories and misinformation. Pharmacists must educate patients and consumers.

How pharmacists can support patients with arthritis

Arthritis Australia has launched a National Strategic Action Plan which resolves to prevent arthritis, invest in research, and improve treatment and support for people...